AMANDA HADDOX: Open Payments
NPI 1184072886 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 31 payments from 13 companies in 2025. Trend: 2023 $325 · 2024 $618 · 2025 $655
Food & beverage: $587Education: $68
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| PFIZER INC. | 7 | $112 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| ARRAY BIOPHARMA INC | 2 | $55 |
| Tempus AI, Inc | 2 | $40 |
| Celgene Corporation | 2 | $37 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Genentech USA, Inc. | 1 | $23 |
Products named: REBLOZYL, IBRANCE, IMFINZI, XTANDI, XALKORI, OPDUALAG, XT CDX, Enhertu.
Industry payments across WV — which companies pay providers there.
